Louise Wang Zhiying Humphrey

Array ( [id] => 4407546 [patent_doc_number] => 06300134 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-09 [patent_title] => 'RNA transformation vectors derived from a single-component RNA virus and contain an intervening sequence between the cap and the 5\' end' [patent_app_type] => 1 [patent_app_number] => 9/502711 [patent_app_country] => US [patent_app_date] => 2000-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 6 [patent_no_of_words] => 16757 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/300/06300134.pdf [firstpage_image] =>[orig_patent_app_number] => 502711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5888428 [patent_doc_number] => 20020012914 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-31 [patent_title] => 'METHOD FOR TRANSFERRING NUCLEIC ACID INTO MULTICELLED EUKARYOTIC ORGANISM CELLS AND COMBINATION THEREFOR' [patent_app_type] => new [patent_app_number] => 09/446690 [patent_app_country] => US [patent_app_date] => 2000-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13230 [patent_no_of_claims] => 89 [patent_no_of_ind_claims] => 62 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0012/20020012914.pdf [firstpage_image] =>[orig_patent_app_number] => 09446690 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1484704 [patent_doc_number] => 06365351 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-02 [patent_title] => 'Non-invasive method for detecting target RNA' [patent_app_type] => B1 [patent_app_number] => 09/493494 [patent_app_country] => US [patent_app_date] => 2000-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 11 [patent_no_of_words] => 11532 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/365/06365351.pdf [firstpage_image] =>[orig_patent_app_number] => 09493494 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1365574 [patent_doc_number] => 06566099 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-20 [patent_title] => 'Nucleic acid encoding a chimeric polypeptide' [patent_app_type] => B1 [patent_app_number] => 09/491759 [patent_app_country] => US [patent_app_date] => 2000-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 13855 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/566/06566099.pdf [firstpage_image] =>[orig_patent_app_number] => 09491759 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 985371 [patent_doc_number] => 06924099 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-08-02 [patent_title] => 'Biomarkers and assays for carcinogenesis' [patent_app_type] => utility [patent_app_number] => 09/490609 [patent_app_country] => US [patent_app_date] => 2000-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10035 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/924/06924099.pdf [firstpage_image] =>[orig_patent_app_number] => 09490609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1236376 [patent_doc_number] => 06689865 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-02-10 [patent_title] => 'Nucleic acid molecules encoding DRT111 and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/488498 [patent_app_country] => US [patent_app_date] => 2000-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 30391 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/689/06689865.pdf [firstpage_image] =>[orig_patent_app_number] => 09488498 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1565331 [patent_doc_number] => 06339071 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-15 [patent_title] => 'Antisense oligonucleotide modulating cyclin E gene expression and therapeutic uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/488074 [patent_app_country] => US [patent_app_date] => 2000-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 6951 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 37 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/339/06339071.pdf [firstpage_image] =>[orig_patent_app_number] => 09488074 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4335754 [patent_doc_number] => 06333194 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-25 [patent_title] => 'Hydrogel compositions for controlled delivery of virus vectors and methods of use thereof' [patent_app_type] => 1 [patent_app_number] => 9/487854 [patent_app_country] => US [patent_app_date] => 2000-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 9 [patent_no_of_words] => 27663 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/333/06333194.pdf [firstpage_image] =>[orig_patent_app_number] => 487854 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4380170 [patent_doc_number] => 06261840 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-17 [patent_title] => 'Antisense modulation of PTP1B expression' [patent_app_type] => 1 [patent_app_number] => 9/487368 [patent_app_country] => US [patent_app_date] => 2000-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38005 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/261/06261840.pdf [firstpage_image] =>[orig_patent_app_number] => 487368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4337627 [patent_doc_number] => 06333314 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-25 [patent_title] => 'Liposomes containing oligonucleotides' [patent_app_type] => 1 [patent_app_number] => 9/482084 [patent_app_country] => US [patent_app_date] => 2000-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6391 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/333/06333314.pdf [firstpage_image] =>[orig_patent_app_number] => 482084 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6692528 [patent_doc_number] => 20030039960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-27 [patent_title] => 'Therapeutic treatment' [patent_app_type] => new [patent_app_number] => 09/482794 [patent_app_country] => US [patent_app_date] => 2000-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3874 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20030039960.pdf [firstpage_image] =>[orig_patent_app_number] => 09482794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6765540 [patent_doc_number] => 20030099939 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-29 [patent_title] => 'NUCLEIC ACID LADDERS' [patent_app_type] => new [patent_app_number] => 09/472067 [patent_app_country] => US [patent_app_date] => 1999-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5681 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20030099939.pdf [firstpage_image] =>[orig_patent_app_number] => 09472067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7645756 [patent_doc_number] => 06472213 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-29 [patent_title] => 'Shuttle vectors for the introduction of DNA into mycobacteria and utilization of such bacteria as vaccines' [patent_app_type] => B1 [patent_app_number] => 09/468543 [patent_app_country] => US [patent_app_date] => 1999-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4516 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/472/06472213.pdf [firstpage_image] =>[orig_patent_app_number] => 09468543 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 443000 [patent_doc_number] => 07256171 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-08-14 [patent_title] => 'Use of core 2 G1cNAc transferase inhibitors in treating inflammation' [patent_app_type] => utility [patent_app_number] => 09/856391 [patent_app_country] => US [patent_app_date] => 1999-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19543 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/256/07256171.pdf [firstpage_image] =>[orig_patent_app_number] => 09856391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6800789 [patent_doc_number] => 20030095953 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-22 [patent_title] => 'METHODS OF REVERSING DRUG RESISTANCE IN CANCER CELLS' [patent_app_type] => new [patent_app_number] => 09/439293 [patent_app_country] => US [patent_app_date] => 1999-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11971 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0095/20030095953.pdf [firstpage_image] =>[orig_patent_app_number] => 09439293 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1135625 [patent_doc_number] => 06784340 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-08-31 [patent_title] => 'Chemical inducible promoter used to obtain transgenic plants with a silent marker' [patent_app_type] => B1 [patent_app_number] => 09/438392 [patent_app_country] => US [patent_app_date] => 1999-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 32 [patent_no_of_words] => 17771 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/784/06784340.pdf [firstpage_image] =>[orig_patent_app_number] => 09438392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4257379 [patent_doc_number] => 06258571 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-10 [patent_title] => 'High throughput DNA sequencing vector' [patent_app_type] => 1 [patent_app_number] => 9/438142 [patent_app_country] => US [patent_app_date] => 1999-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 27 [patent_no_of_words] => 32002 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/258/06258571.pdf [firstpage_image] =>[orig_patent_app_number] => 438142 [rel_patent_id] =>[rel_patent_doc_number] =>)